COMPANY PROFILE

GenePlus / 吉因加

Explore full profile

Beijing AI clinical-NGS and multiomics precision-medicine platform

ChinaFounded 2015Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2025

Total funding $100–500M Disclosed equity funding

Unlock exact values

About GenePlus / 吉因加

GenePlus / 吉因加 (Beijing Gene+ Technology) is a Beijing AI-enabled precision-medicine and clinical-NGS platform founded in 2015. The company delivers automated NGS diagnostic solutions, pharma companion and biomarker services, and clinical-research multiomics spanning more than 30 provinces plus overseas channels. Offerings cover oncology and pathogen assays, library workshops, sequencers and informatics on DNBSEQ-class platforms, with MRD and multi-gene assays for hospitals and CRO partners. Mid-size China NGS leftover beyond MyGenostics ADD, Pack 39 AmoyDx and iGeneTech FIX, and MGI mega — city-level Beijing HQ (not Dongcheng District pin).

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: China
Open positions: None listed
Dealroom signal: 23.0/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Testing, Oncology, Tech for Hospitals and Clinics, medical testing, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES DOther financing	Dec 2025	$42M	$876M	Prosperity Investment · Chang Development	↗
SERIES COther financing	Jul 2021	$116M	$464M	AliHealth · Baidu Ventures · CCB International · Notable Capital	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

GenePlus / 吉因加 website traffic

Latest recorded traffic for GenePlus / 吉因加 is 1.3K monthly website visits, down 85.2% over the last three months.

Latest monthly visits1.3K 3-month web change-85.2%

Monthly website visitsJun 2018–May 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MImiDiagnosticsSilicon chip diagnostics for rapid, lab-quality results	Leuven, Belgium	Operational	61	$103M	$132M
FRFreenomeA health technology company developing accurate, accessible and non-invasive disease screening products	San Francisco, United States	Operational
ESEpic SciencesDiagnostics company that's improving cancer management by providing real-time biopsy material to guide personalized medicine	University City, United States	Operational
PRPreneticsAims to give millions of people personalized information about the health of their bodies to help them confidently make choices about their lives	Eastern District, Hong Kong	Operational
NLNeoGenomics LaboratoriesCancer Reference laboratory	Fort Myers, United States	Operational
CECellswayMicrofluidic liquid biopsy platform for isolating tumor cells	London, United Kingdom	Operational
SYSyantraPrecision healthcare company that focuses on the commercialization of breast cancer detection blood tests	Calgary, Canada	Operational
BIBiofidelityRapid genomic biomarker detection for precision oncology	Cambridge, United Kingdom	Operational